Abstract
The ultrastructure of the Type I cells in paraganglia of rat recurrent laryngeal nerve (RLN) was studied after the administration of 5-hydroxydopamine (5-OHDA) and 6-hydroxydopamine (6-OHDA).
Normal Type I cells of RLN-paraganglia contained abundant organelles and their cytoplasm was characterized by the presence of numerous membranebounded dense-cored vesicles (DCVs). The DCVs were round in profile (diameter 107.67±0.06nm, all values expressed as mean±s. e. m. in the present study) and possessed dense cores of moderate to low electron density. After 5-OHDA treatment (single injection, 100mg/kg b. w., i. v.), the majority of DCVs were filled with a material of high electron density. No significant difference was observed between the profile diameter of the DCVs in 5-OHDA-treated rats (104.96±0.06nm) and that in normal rats. After 6-OHDA treatment (three injections, 100mg/kg b. w. each at 12h intervals i. p.), no significant alteration in the electron density of the core was noted. However, most of the DCVs were enlarged and round, elliptical or irregular in profile (190.57±2.77nm×130.34±2.09nm). The dense core of DCVs was centrally or eccentrically located in DCVs.
The results of the present study indicate that: 1) there is only one type of granulated glomus cell (i. e., Type I cells) in the rat RLN-paraganglia under normal physiological condition; and 2) since the ultrastructural morphology of DCVs in Type I cells of rat RLN-paraganglia is altered after 5-OHDA or 6-OHDA treatment, these cells may possess mechanisms for the uptake of false adrenergic neurotransmitter and/or neurotoxin.
